Table 3.
Product Name | Company | Approved for Condition | Description | Reference |
---|---|---|---|---|
Fluzone | Sanofi Pasteur Inc. | Influenza Virus Vaccine (USFDA) | Micro-injection system for intradermal delivery of vaccine | [271] |
Intanza | Sanofi Pasteur Europe | Split virion, Inactivated Influenza vaccine (EMA) (Discontinued due to commercial issues) |
Micro-injection system of a prefilled syringe, having a 1.5 mm needle length. The needle shielding system is provided, which covers the needle after use. | [272] |
C-8 (Cosmetic type) | The Dermaroller Series by Anastassakis K | Cosmetic use. | It has a 0.13 mm needle length. It enhances the penetration of topical agents | [273] |
C-8HE (Hair-bearing surface) | Cosmetic Use | It has a 0.2 mm. needle length. The length is below the pain threshold, so painless delivery | [273] | |
CIT-8 (Collagen Induction Therapy) | Medical type | It is used for collagen induction and skin remodeling therapy. It has a 0.5 mm needle length. | [273] | |
MF-8 | Creating deeper microchannels on the epidermis | Needle length of 1.5 mm, its deep penetration is targeted for destroying bundles of scar collagen | [273] | |
MS-4 | Facial acne scars | The needles have 1.5 mm in length and 4 circular arrays. Its use is preferred where better precision and penetration in deep location is required. | [273] |